Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Breast Neoplasms, Male × Gonadotropin-Releasing Hormone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 15 Breast Neoplasms 10 Neoplasm Metastasis 3 Neoplasms by Site 2 Neoplasms 2 Breast Diseases 2 Sleep Wake Disorders 1 Skin Diseases 1 Salivary Gland Adenoma, Pleomorphic 1 Osteoporosis 1 Leiomyoma 1 Hemorrhage 1 Fatigue 1 Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1 Breast Neoplasms, Male 1

Interventions

exemestane 3 Paclitaxel 3 Goserelin 3 pegfilgrastim 2 Tamoxifen 2 Leuprolide 2 Letrozole 2 Cyclophosphamide 2 trastuzumab biosimilar HLX02 1 ribociclib 1 Zoledronic Acid 1 Trastuzumab 1 Taxes 1 Radiotherapy 1 Radiosurgery 1 Pyridoxine 1 Prochlorperazine 1 Palonosetron 1 PF-05280014 1 Ontruzant 1 Ogivri 1 Methotrexate 1 Metformin 1 Lapatinib 1 Ibandronic Acid 1 Granisetron 1 Gonadotropin-Releasing Hormone 1 Fluorouracil 1 Fentanyl 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01638247 2018-09-19

MALE

GBG Forschungs GmbH

Phase 3 Completed

Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon ⚡